McCourt M, Wang J H, Sookhai S, Redmond H P
Department of Surgery, Professorial Unit, Cork University Hospital, Ireland.
Arch Surg. 1999 Dec;134(12):1325-31; discussion 1331-2. doi: 10.1001/archsurg.134.12.1325.
Vascular endothelial growth factor (VEGF; vascular permeability factor) is one of the most potent proangiogenic cytokines, and it plays a central role in mediating the process of angiogenesis or new blood vessel formation. Neutrophils (PMNs) recently have been shown to produce VEGF.
The acute inflammatory response is a potent stimulus for PMN-directed angiogenesis.
Neutrophils were isolated from healthy volunteers and stimulated with lipopolysaccharide (LPS), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and anti-human Fas monoclonal antibody. Culture supernatants were assayed for VEGF using enzyme-linked immunosorbent assays. Culture supernatants from LPS- and TNF-alpha-stimulated PMNs were then added to human umbilical vein endothelial cells and human microvessel endothelial cells and assessed for endothelial cell proliferation using 5-bromodeoxyuridine labeling. Tubule formation was also assessed on MATRIGEL basement membrane matrix. Neutrophils were lysed to measure total VEGF release, and VEGF expression was detected using Western blot analysis.
Lipopolysaccharide and TNF-alpha stimulation resulted in significantly increased release of PMN VEGF (532+/-49 and 484+/-80 pg/mL, respectively; for all, presented as mean +/- SEM) compared with control experiments (32+/-4 pg/mL). Interleukin 6 and Fas had no effect. Culture supernatants from LPS- and TNF-alpha-stimulated PMNs also resulted in significant increases (P<.005) in macrovascular and microvascular endothelial cell proliferation and tubule formation. Adding anti-human VEGF-neutralizing polyclonal antibody to stimulated PMN supernatant inhibited these effects. Total VEGF release following cell lysis and Western blot analysis suggests that the VEGF is released from an intracellular store.
Activated human PMNs are directly angiogenic by releasing VEGF, and this has important implications for inflammation, capillary leak syndrome, wound healing, and tumor growth.
血管内皮生长因子(VEGF;血管通透因子)是最有效的促血管生成细胞因子之一,在介导血管生成或新血管形成过程中起核心作用。最近研究表明中性粒细胞(PMN)可产生VEGF。
急性炎症反应是PMN介导血管生成的有效刺激因素。
从健康志愿者中分离出中性粒细胞,并用脂多糖(LPS)、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)和抗人Fas单克隆抗体进行刺激。使用酶联免疫吸附测定法检测培养上清液中的VEGF。然后将LPS和TNF-α刺激的PMN培养上清液添加到人脐静脉内皮细胞和人微血管内皮细胞中,使用5-溴脱氧尿苷标记评估内皮细胞增殖。还在基质胶基底膜基质上评估小管形成。裂解中性粒细胞以测量VEGF总释放量,并使用蛋白质印迹分析检测VEGF表达。
与对照实验(32±4 pg/mL)相比,脂多糖和TNF-α刺激导致PMN释放的VEGF显著增加(分别为532±49和484±80 pg/mL;所有数据均表示为平均值±标准误)。白细胞介素6和Fas无作用。LPS和TNF-α刺激的PMN培养上清液也导致大血管和微血管内皮细胞增殖及小管形成显著增加(P<0.005)。向刺激的PMN上清液中添加抗人VEGF中和多克隆抗体可抑制这些作用。细胞裂解后的VEGF总释放量及蛋白质印迹分析表明VEGF从细胞内储存中释放。
活化的人PMN通过释放VEGF直接促进血管生成,这对炎症、毛细血管渗漏综合征、伤口愈合和肿瘤生长具有重要意义。